<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ifp="http://www.ifactory.com/press" ifp-element-xpath="/*[local-name() = 'urlset' and namespace-uri() = 'http://www.sitemaps.org/schemas/sitemap/0.9']"><ifp:contentType>ARTICLE</ifp:contentType><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p123.xml</sm:loc><ifp:title>NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p123.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p115.xml</sm:loc><ifp:title>Inflammatory Myofibroblastic Tumor Driven by Novel NUMA1-ALK Fusion Responds to ALK Inhibition</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p115.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Inflammatory Myofibroblastic Tumor Driven by Novel NUMA1-ALK Fusion Responds to ALK Inhibition</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p108.xml</sm:loc><ifp:title>Letter to the Editor: Chicken Noodle Soup (Capsule) for the Soul?</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p108.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Letter to the Editor: Chicken Noodle Soup (Capsule) for the Soul?</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p107.xml</sm:loc><ifp:title>Extending Our Reach—Will Telemedicine Get Us There?</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p107.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Extending Our Reach—Will Telemedicine Get Us There?</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-pxxiii.xml</sm:loc><ifp:title>NCCN News</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-pxxiii.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN News</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-pxxix.xml</sm:loc><ifp:title>Oncology Research Program</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-pxxix.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Oncology Research Program</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p170.xml</sm:loc><ifp:title>Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p170.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p201.xml</sm:loc><ifp:title>Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p201.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p144.xml</sm:loc><ifp:title>The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p144.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p162.xml</sm:loc><ifp:title>Real-World Impact of a Decision Support Tool on Colony-Stimulating Factor Use and Chemotherapy-Induced Febrile Neutropenia Among Patients With Breast Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p162.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Real-World Impact of a Decision Support Tool on Colony-Stimulating Factor Use and Chemotherapy-Induced Febrile Neutropenia Among Patients With Breast Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p153.xml</sm:loc><ifp:title>Skeletal Muscle Quality Beyond Average Muscle Attenuation: A Proposal of Skeletal Muscle Phenotypes to Predict Short-Term Survival in Patients With Endometrial Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p153.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Skeletal Muscle Quality Beyond Average Muscle Attenuation: A Proposal of Skeletal Muscle Phenotypes to Predict Short-Term Survival in Patients With Endometrial Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p136.xml</sm:loc><ifp:title>Description of Venous Thromboembolism in Hospitalized Patients With Metastatic Cancer: A National Sample</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p136.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Description of Venous Thromboembolism in Hospitalized Patients With Metastatic Cancer: A National Sample</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p211.xml</sm:loc><ifp:title>Secondary Neoplasms of the Female Lower Genital Tract After Hematopoietic Cell Transplantation</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p211.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Secondary Neoplasms of the Female Lower Genital Tract After Hematopoietic Cell Transplantation</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p221.xml</sm:loc><ifp:title>In Memoriam: Jimmie C. Holland, MD (1928–2017)</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/16/2/article-p221.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>In Memoriam: Jimmie C. Holland, MD (1928–2017)</ifp:title></sm:url></urlset>
